Erbitux fails to stop colon cancer before it spreads
Eli Lilly and Co. and Merck KGaA drug failed to slow tumors in a study designed to expand the medicine’s use to patients whose
disease is in an earlier stage.
Bloomberg News
Articles
Genetic testing could spur Erbitux drug sales
The drugmakers are counting on screening for the so-called K-ras gene to spur use of Erbitux in metastatic colorectal cancer.
Feds: AMC must sell some Indy theaters to make acquisition
The U.S. Justice Department said AMC Entertainment Group Inc., the second-largest U.S. movie theater owner, must sell some
cinemas to proceed with plans to buy most of those operated by Kerasotes Showplace Theatres.
Drug-spending increase highest in four years
The price increase was fueled by the debate over the health-care overhaul in Washington, D.C., Medco Health Solutions Inc. CEO David Snow said.
Lilly, others cut U.S. tax bills through transfer pricing
U.S. companies, including Eli Lilly, amassed at least $1 trillion in foreign profits not taxed in the U.S. as of the end of
last year. That cumulative total increased 70 percent over three years.
Report: WellPoint, Aetna may need relief from cost mandate
The U.S. health overhaul’s mandate that insurers spend 80 percent of premiums on medical care may
need to be loosened
to keep companies from quitting the market for people who buy coverage on their own, state regulators said.
WellPoint, others may need relief from law’s spending mandate
The health law passed by Congress in March will force insurers like WellPoint to give rebates to customers next year if the
companies don’t meet the medical-spending minimums.
General Growth still backing Brookfield despite new Simon bid
General Growth Properties Inc. rejected Simon Property Group Inc.’s “best and final” offer.
Simon Property makes ‘final’ General Growth offer
Simon Property says its latest offer is worth $6.5 billion, or $20 a share, for General Growth. It had last offered $18.25
a share.
Lilly sues to block copy of Evista osteoporosis drug
Watson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.’s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.
General Growth hearing delayed as Simon makes new bid
General Growth said the hearing before U.S. Bankruptcy Judge Allan Gropper has been moved from Wednesday to Friday.
Obama plans tougher rules on for-profit colleges
The administration is gearing up to produce tougher regulations that may reduce the amount of federal financial aid flowing
to for-profit colleges such as locally-based ITT Educational.
Simon Property steps up fight for General Growth
The latest proposal is the Indianapolis-based company’s third attempt to buy or gain a piece of the No. 2 mall owner.
General Growth backs new Brookfield plan over Simon offer, source says
General Growth Properties Inc. plans to back a revised bankruptcy exit plan proposed by Brookfield Asset Management Inc. over
a competing offer by Simon Property Group Inc.
Simon Property cooperating With FTC on Prime Outlets inquiry
Some retail tenants of outlet malls are concerned about Simon gaining too much market power should its acquisition of Prime
Outlets be approved.
Simon Property earnings fall on debt-retirement expenditures
Funds from operations fell to $325.6 million, or 94 cents a share, from $476.8 million, or $1.61 a year earlier, the Indianapolis-based
shopping mall giant said Friday morning.
Blackstone may join General Growth plan, Simon says
Simon Property Group and Blackstone Group LP are in “ongoing discussions” for an investment in General Growth after the mall
operator turned down a $10 billion takeover bid from Simon in February, CEO David Simon said.
Judge rejects Guidant’s defibrillator plea deal
A federal judge has rejected Guidant Corp.'s guilty plea to charges it hid defects in heart defibrillators, after some
doctors and patients complained about the $296 million deal.
General Growth hearing delayed to weigh bids
General Growth Properties Inc., the second-biggest U.S. mall owner, said a bankruptcy court hearing on its auction process
will be delayed five days to give the company time to consider competing bids, including one from Indianapolis-based Simon
Property Group.
U.S. farmers planting corn at record pace
U.S. corn farmers may have planted more acres last week than in any week ever as dry weather
and more-productive equipment sped up fieldwork.